In the primary prevention level (Table 7), vitamin D analogs ONS failed to induce significant changes in PSA concentrations among men with BPH compared with placebo [154,155,156], indicating a possible lack of efficacy. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.